caseism

Respironics, Inc.: Take a Deep Breath [bestseller] Case Solution & Answer

Chief Executive Officer of Respironics, John Miclot decided to take the company to NASDAQ in Times Square. This event take place as the company celebrates 30th anniversary of its founding. The revenues in 2006 touched $ 1 Billion for the first time. The company has been successful in winning several awards for its services related to sleep diagnostic tools and flow generators used for treating patients. Respironics stock price has been mercurial. A declining market share has been observed in sleep therapy equipment market. However its competitor ResMed, Inc., has been observing a robust increase in revenue. The situation is precarious and requires concrete steps to be handled effectively. Respironics should continue its diversification drive of acquiring other medical device corporations. It can also desire to be acquired by some other global healthcare company. Miclot and his top management team decided to scrutinize different options and tools available to make Respironics a success.
Respironics, Inc. Take a Deep Breath bestseller case solution

Share This

LOOK FOR A FREE CASE STUDY SOLUTION

JUST REGISTER NOW AND GET 50% OFF ON EACH CASE STUDY